Table 1 Results of univariate analyses between the CTS group and the control group
From: Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
Variables | CTS group | Control group | p-value | OR (95% CI) |
|---|---|---|---|---|
(n =997) | (n =594) | |||
T2DM | 115 (11.5) | 43 (7.2) | 0.006 | 1.67 (1.16-2.41) |
Gender (female) | 710 (71.2) | 293 (49.3) | <0.001 | 2.54 (2.06-3.14) |
Age (years) | 55.7 ± 15.2 | 49.3 ± 13.0 | <0.001 | 1.03 (1.02-1.04) |
BMI (kg/m2)a | 28.3 ± 5.4 | 26.7 ± 4.6 | <0.001 | 1.06 (1.04-1.09) |
Systolic RR (mmHg) | 138.8 ± 21.4 | 138.6 ± 20.6 | 0.870 | 1.00 (0.99-1.01) |
Age DM patients (years) | 65.6 ± 12.7 | 60.1 ± 13.7 | 0.021 | 1.03 (1.01-1.06) |
Gender DM patients (female) | 74 (64.3%) | 21 (48.8%) | 0.078 | 1.89 (0.93-3.84) |
BMI DM patients (kg/m2) | 31.2 ± 5.7 | 29.1 ± 5.1 | <0.001 | 1.07 (1.04-1.10) |
Median diabetes duration (months)b | 103 (55–172) | 80 (47–166) | 0.389 | 1.00 (1.00-1.01) |
HbA1c (% (mmol/mol))c | 7.1 ± 3.2 (54 ± 11) | 7.3 ± 3.2 (56 ± 12) | 0.567 | 0.99 (0.95-1.03) |
Microvascular complicationsd | 46 (40.0%) | 13 (30.2%) | 0.402 | 0.68 (0.28-1.67) |
Metformin | 69 (60.0%) | 26 (60.5%) | 0.582 | 1.15 (0.70-1.89) |
SU-derivate | 34 (29.6%) | 7 (16.3%) | 0.09 | 2.19 (0.89-5.40) |
Insulin | 52 (45.2%) | 18 (41.9%) | 0.673 | 1.17 (0.57-2.37) |